Sinomenine
CAS No. 115-53-7
Sinomenine ( Sinomenine | Coculine | Cucoline | Kukoline )
产品货号. M17841 CAS No. 115-53-7
青藤碱是从青藤碱中分离出来的纯生物碱,用于治疗风湿病和关节炎。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 100MG | ¥405 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Sinomenine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述青藤碱是从青藤碱中分离出来的纯生物碱,用于治疗风湿病和关节炎。
-
产品描述Sinomenine is an alkaloid originally isolated from the root of the plant Sinomenium acutum. It is used in traditional medicine in China to treat rheumatic arthritis. Sinomenine has a wide spectrum analgesic effect in rodent models of nociceptive, inflammatory and neuropathic pain.
-
体外实验Cell viability gradually decreased with increasing Sinomenine concentration. The migration ability of MDA-MB-231 cells is significantly weakened by 0.25, 0.5, and 1 mM of Sinomenine treatment. The wound-healing assay reveals that 0.25 and 0.5 mM Sinomenine significantly suppress the healing of the wound. When the MDA-MB-231 cells are treated with 0.5 mM Sinomenine, the healing progress is about 50%, but in the group treated with 0.25 mM Sinomenine and the untreated control, the healing is about 80% and nearly 95%, respectively. The IB assay following inhibitor of NF-κB (IκB) antibody IP shows that the binding of NF-κB to IκB is inhibited by Sinomenine treatment in a dose-dependent manne.
-
体内实验Sinomenine (i.p.) produces antinociception in the hot plate and tail flick tests in male rats at 40 mg/kg, but not at lower doses (10 or 20 mg/kg). At 10 to 40 mg/kg Sinomenine does not produce any observable side effect such as sedation, allergy or motor impairments. Antinociception is also seen mice at 60 min following 80 mg/kg i.p. Sinomenine, but not at lower doses (20 or 40 mg/kg), in the tail flick test. Sinomenine at 80 mg/kg i.p. does not produce any observable side effects in mice. I.p or p.o. Sinomenine at 40 or 80 mg/kg dose-dependently reduces mechanical hypersensitivity in nerve injured mice. I.p. Sinomenine at 40 mg/kg, but not lower doses or vehicle, significantly decreases mechanical and cold allodynia for up to 240 min without producing motor deficits or sedation. At doses of 10 to 40 mg/kg, Sinomenine dose-dependently increases the paw withdrawal threshold.In non-chronic constriction injury (CCI) healthy rats, Sinomenine at the dose range of 10 to 40 mg/kg does not change the immobility behavior in the forced swimming test.
-
同义词Sinomenine | Coculine | Cucoline | Kukoline
-
通路Angiogenesis
-
靶点VEGFR
-
受体Others
-
研究领域Others-Field
-
适应症——
化学信息
-
CAS Number115-53-7
-
分子量329.4
-
分子式C19H23NO4
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 50 mg/mL (151.80 mM)
-
SMILESCN1CC[C@@]23CC(=O)C(=C[C@@H]2[C@@H]1Cc1c3c(c(cc1)OC)O)OC
-
化学全称(9alpha,13alpha,14alpha)-7,8-Didehydro-4-hydroxy-3,7-dimethoxy-17-methylmorphinan-6-one
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Liu L, et al. Int J Immunopharmacol, 1996, 18(10), 529-543.
产品手册
关联产品
-
AMPK-IN-3
AMPK-IN-3 (化合物 67) 是一种强效的、选择性的 AMPK 抑制剂,其对AMPK (α2)、AMPK (α1) 和 KDR 的 IC50 值分别为 60.7、107 和 3820 nM。AMPK-IN-3 对 AMPK 的抑制不影响细胞活力或导致 K562 细胞的明显细胞毒性。AMPK-IN-3 可用于癌症的研究。
-
Cabozantinib (S-mala...
Cabozantinib (XL184) 是一种有效的多激酶抑制剂,可抑制 VEGFR2、c-Met、Kit、Axl 和 Flt3,IC50 分别为 0.035、1.3、4.6、7 和 11.3 nM。
-
(Z)-FeCP-oxindole
(Z)-FeCP-oxindole 是一种选择性的人血管内皮细胞生长因子受体 2 (VEGFR2) 抑制剂,其 IC50 值为 200 nM。(Z)-FeCP-oxindole 在 10 μM 时可以显著抑制 VEGFR1 和 PDGFRa 或 b。(Z)-FeCP-oxindole 具有一定的抗癌活性,作用于 B16 鼠黑色素瘤系的 IC50 < 1 μM。
021-51111890
购物车()
sales@molnova.cn

